Chemotherapy Alone and Chemotherapy Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Pancreatic Cancer
DOI:
https://doi.org/10.48047/tkckpe81Keywords:
Chemotherapy, Advanced Pancreatic Cancer, ChemoradiotherapyAbstract
Background: Locally advanced pancreatic cancer (LAPC) remains a formidable therapeutic challenge, with most patients presenting at an unresectable stage. The optimal management strategy for LAPC continues to be debated, particularly the role of chemoradiotherapy (CRT) following induction chemotherapy.
Downloads
References
Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol. 2019;10(1):10-27. doi:10.14740/wjon1166
Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: Cancer today. International Agency for Research on Cancer. Published 2020. Accessed May 22, 2025. https://gco.iarc.fr/
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.